IC5 Warfarin Flashcards
Warfarin exists as a racemate
Which enantiomer is the active one?
S-enantiomer
What are the metabolic pathways involved in Warfarin?
CYP2C9 (S-Warfarin => 7-OH Warfarin)
VKORC1
Others (less significant)
- CYP4F2
- CYP2C18
- NQO1
VS R-Warfarin
- Metabolised by CYP3A4, CYP2C19, CYP1A2
What are some factors contributing to interindividual differences in Warfarin response?
- Genetic factors (polymorphisms) [41%]
- Clinical and environmental factors (age, height, weight, race, gender, interaction medicine, diet, smoking, alcohol) [10%]
- Others: pharmacomicrobiome, pharmacoepigenetic [49%]
Which clotting factor plunges the fastest when Warfarin is dosed?
Which plunges the slowest?
Factor VII - half-life of 4-6h
Factor II - half-life of 42-72h
Why might the initial rise in INR be rapid when high doses of Warfarin is used?
Because Factor VII plunges fast
When is anticoagulated state achieved?
When Factor II declines to a certain level (takes ~3-5 days)
Monitoring parameter if Warfarin is the _____
Does it measure all factors involved?
INR
Only measures factors II, VII, X (from common + extrinsic pathway)
Does not measure factor IX
Explain why Warfarin confers an initial hypercoagulable state (thereby requiring 5 days overlap with LMWH when used in VTE)
Warfarin reduces natural anticoagulants, Protein C and Protein S as well (Protein C depletes quickly - half-life 9h)
Is loading dose required for Warfarin?
No
- Warfarin has slow onset of action (24-72h), does not improve with loading dose
- Therapeutic INR achieved within 3-5 days without loading dose
Local setting:
- load when there’s an existing clot, or when pt wants to be discharged asap
Initial and maintenance dose of Warfarin in local context
- Initiate: 5mg => 3/5mg => 3mg
- Maintenance for chinese/malays: 2-3mg/day
- Maintenance for indians: 4-5mg/day
- Also note that elderly/frail/undernourished/hypoalbuminemia/hepatic or renal impairment/acute illness/high bleeding risk/DDIs with CYP inhibitor or inducer => may have increased sensitivity, and hence require lower doses
bc chinese/malays have mutation of VKORC1, more sensitive to Warfarin thus require lower maintenance dose
Warfarin dose adjustments
Renal:
- eGFR <60/ESKD/HD/PD: decrease dose by 10-20% (because uremia suppresses the action of CYP enzymes. Hence downregulation of CYP enzyme causes warfarin accumulation, thus reduce dose)
- ESKD/HD/PD: decrease dose by 20%
- CRRT/PIRRT: avoid use
- CI in severe renal impairment (stage 5 CKD)
Hepatic:
- NIL
- CI in severe hepatic impairment (child-pugh C)
What impacts Warfarin maintenance dose?
- body surface area
- age
- target INR
- race (chinese/malays vs indians)
- current thrombosis
- current amiodarone use
- smokers
- gender
- coronary artery disease
- heart failure
- diabetes
Which of the following factors is a/w INR stability or INR instability:
- Age >=70y
- Absence of chronic disease
- Congestive heart failure
- Diabetes
- Target range for INR >= 3
INR Stability
- Age >=70y
- Absence of chronic disease
INR instability
- Congestive heart failure
- Diabetes
- Target range for INR >= 3
List some common CYP2C9 inhibitors
- Amiodarone
- Fluconazole (other Azoles have much less interaction)
- Metronidazole
- Sulfamethoxazole/Trimethorprim
- Isoniazid
- Efavirenz
- Ceritinib
- Isoniazid
- Allopurinol
- PPIs
- Salicylates
List some common CYP2C9 inducers
- Rifampicin
- Ritonavir
- Carbamazepine
- Phenobarbital
- St John’s Wort
- Barbiturates
- Corticosteroids (?)
- Spironolactone (?)
- Thiazide diuretics (?)